Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 41Leukemia 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myelodysplastic Syndromes 21Congenital Abnormalities 9Recurrence 8Lymphoma, Non-Hodgkin 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma 7Leukemia, Myelomonocytic, Chronic 6Leukemia, Lymphocytic, Chronic, B-Cell 6Hodgkin Disease 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Leukemia, Biphenotypic, Acute 5Neoplasms 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Burkitt Lymphoma 4Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Juvenile 3Neoplasm, Residual 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell 2Leukemia, Prolymphocytic 2

Interventions

merphos 3Tacrolimus 3Methotrexate 3Peripheral Blood Stem Cell Transplantation 2Flow Cytometry 2Cytogenetic Analysis 2Cytarabine 2Cyclosporine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1adavosertib 1Whole-Body Irradiation 1Vorinostat 1Sirolimus 1Pharmacogenomic Testing 1Mycophenolic Acid 1In Situ Hybridization, Fluorescence 1Enzyme-Linked Immunosorbent Assay 1Deferasirox 1Clofarabine 1Azacitidine 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Chromosome 5q Deletion Syndrome × Clofarabine × Clear all
NCT00839982 2017-07-11

Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Fred Hutchinson Cancer Center

Phase 1/2 Completed
35 enrolled 11 charts
Other hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡